JER

(2~{S})-3-[4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy]propane-1,2-diol

Created:	2021-05-27
Last modified:	2021-09-29

Find Related PDB Entry
1 entries where JER is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	1
Bond Count	67
Aromatic Bond Count	17

2D diagram of JER

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2~{S})-3-[4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy]propane-1,2-diol
Systematic Name (OpenEye OEToolkits)	(2~{S})-3-[4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy]propane-1,2-diol
Formula	C₂₅ H₃₁ N₃ O₅
Molecular Weight	453.531
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCc1cc(cc(C)c1OC[CH](O)CO)c2noc(n2)c3cc(OC)nc(c3)C4CCCC4
SMILES	OpenEye OEToolkits	2.0.7	CCc1cc(cc(c1OCC(CO)O)C)c2nc(on2)c3cc(nc(c3)OC)C4CCCC4
Canonical SMILES	CACTVS	3.385	CCc1cc(cc(C)c1OC[C@@H](O)CO)c2noc(n2)c3cc(OC)nc(c3)C4CCCC4
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCc1cc(cc(c1OC[C@H](CO)O)C)c2nc(on2)c3cc(nc(c3)OC)C4CCCC4
InChI	InChI	1.03	InChI=1S/C25H31N3O5/c1-4-16-10-18(9-15(2)23(16)32-14-20(30)13-29)24-27-25(33-28-24)19-11-21(17-7-5-6-8-17)26-22(12-19)31-3/h9-12,17,20,29-30H,4-8,13-14H2,1-3H3/t20-/m0/s1
InChIKey	InChI	1.03	KJKKMMMRWISKRF-FQEVSTJZSA-N

Drug Info: DrugBank

DrugBank ID	DB12705
Name	Cenerimod
Groups	investigational
Description	Cenerimod has been used in trials studying the treatment of Systemic Lupus Erythematosus.
Synonyms	Cenerimod
Categories	Alcohols Glycols Oxazoles
CAS number	1262414-04-9

Related Resource References

Resource Name	Reference
PubChem	49871973
ChEMBL	CHEMBL4297505

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.